BioSpace News Archive

Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Tracey Franklin has been appointed Chief Human Resources Officer

Creative Medical Technology Holdings (OTC-CELZ) reported today completion of data analysis and submission of a research paper describing a total of 140 patients treated with the CaverStem® procedure.

X-Chem, Inc. (X-Chem), a privately held biotechnology company focused on applying its next-generation, industry-leading DNA-Encoded library (DEXTM) drug discovery platform to the generation of novel small molecule therapeutics, announced today a drug discovery partnership with Maruho Co., Ltd. (Maruho) to discover lead compounds for novel and challenging targets with applications for human diseases.

DelMar Pharmaceuticals, Inc. announced that the Company has relocated its headquarters from Vancouver, British Columbia to San Diego, California.

NDA Submitted under the FDA’s Accelerated Approval Program

Company to Demonstrate FDA Approved ClearUP Sinus Pain Relief

Finding demonstrates impact, reach of groundbreaking medical research at Northwell Health

Cancer Diagnostics Laboratory has Deep Colorado Roots, History of Subspecialized Pathology and Molecular Testing Services

The global cardiac monitoring and cardiac rhythm management devices market size is poised to grow by USD 4.8 billion during 2019-2023, according to a new report by Technavio, progressing at a CAGR of close to 5% during the forecast period.

This achievement underscores NRGene’s mission to provide the power of genomic solutions to leading agriculture breeding companies to improve yields for the world’s food and biomaterials.